FRAMINGHAM, Mass., April 22, 2014 /PRNewswire/ -- HeartWare
International, Inc. (NASDAQ:HTWR) has scheduled a conference call
to discuss its financial results for the three months ended
March 31, 2014, at 8:00 a.m. U.S. Eastern Daylight Time on
Thursday, May 1, 2014. The
Company plans to release the financial results prior to the
conference call.
The conference call with management will discuss the Company's
financial results, highlights from the first quarter and business
outlook. The call may be accessed by dialing 1-877-407-0789
five minutes prior to the scheduled start time and referencing
"HeartWare." For callers outside the U.S., please dial
+1-201-689-8562.
A live webcast of the call will also be available in the
Investor section at the Company's website
(http://ir.heartware.com/). A replay of the conference call
will be available through the above weblink immediately following
completion of the call.
A copy of the news release announcing results and related
information will be available on the Company's website,
www.heartware.com.
About HeartWare International
HeartWare International develops and manufactures miniaturized
implantable heart pumps, or ventricular assist devices, to treat
Class IIIB / IV patients suffering from advanced heart failure. The
HeartWare® Ventricular Assist System features the
HVAD® pump, a small full-support circulatory assist
device designed to be implanted next to the heart, avoiding the
abdominal surgery generally required to implant competing devices.
The HeartWare System is approved in the
United States for the intended use as a bridge to cardiac
transplantation in patients who are at risk of death from
refractory end-stage left ventricular heart failure, has received
CE Marking in the European Union and has been used to treat
patients in 37 countries. The device is also currently the subject
of a U.S. clinical trial for destination therapy. For additional
information, please visit the Company's website at
www.heartware.com.
HeartWare International, Inc. is a member of the Russell
2000® and its securities are publicly traded on The
NASDAQ Stock Market.
HEARTWARE, HVAD and HeartWare logos are registered trademarks
of HeartWare, Inc.
For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com
Phone: +1 508 739 0864
SOURCE HeartWare International, Inc.